The Prognostic Value of Platelet/Lymphocyte Ratio in Breast Cancer: A Retrospective Analysis

Objective: Because cancer is associated with a systemic inflammatory response in which lymphocytes and platelets play an active role, the platelet/lymphocyte ratio (PLR) has been suggested as a prognostic marker; however, its relationship with breast cancer prognosis remains controversial. The aim of the present study was to investigate the role of PLR as a prognostic factor in patients with breast cancer.Methods: The medical records of patients diagnosed with breast cancer between 2006 and 2013 were reviewed retrospectively. PLR was calculated as the platelet count divided by the lymphocyte count using preoperative hemograms. Receiver operating characteristic (ROC) analysis did not identify a significant PLR cut-off value for overall or disease-free survival. Therefore, patients were divided into two groups according to the median PLR value (<median vs. ≥median; patients with a PLR value equal to the median were assigned to the high-PLR group). Survival was analyzed using the Kaplan-Meier method and the log-rank test.Results: A total of 518 patients were included, and the median PLR was 124. PLR had no significant effect on disease-free survival or overall survival (p>0.05). Similarly, PLR had no significant effect on survival within any of the molecular subtypes (p>0.05).Conclusion: In this retrospective single-center study, PLR dichotomized at the median value of 124 was not associated with overall or disease-free survival in patients with breast cancer in univariable analyses. Prospective multicenter studies with multivariable analyses are needed to clarify the prognostic value of PLR.

Authors

Institutions

Publication Details

Journal
DAHUDER Medical Journal
Published
2026-11-13
DOI
https://doi.org/10.56016/dahudermj.2017508
Primary Topic
Inflammatory Biomarkers in Disease Prognosis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

The Prognostic Value of Platelet/Lymphocyte Ratio in Breast Cancer: A Retrospective Analysis

Yüksel Küçükzeybek, İnci Miray Şahbudak Babadağ
DAHUDER Medical Journal
Inflammatory Biomarkers in Disease Prognosis
article

The Prognostic Value of Platelet/Lymphocyte Ratio in Breast Cancer: A Retrospective Analysis

Yüksel Küçükzeybek, İnci Miray Şahbudak Babadağ
article en

Abstract

Objective: Because cancer is associated with a systemic inflammatory response in which lymphocytes and platelets play an active role, the platelet/lymphocyte ratio (PLR) has been suggested as a prognostic marker; however, its relationship with breast cancer prognosis remains controversial. The aim of the present study was to investigate the role of PLR as a prognostic factor in patients with breast cancer.Methods: The medical records of patients diagnosed with breast cancer between 2006 and 2013 were reviewed retrospectively. PLR was calculated as the platelet count divided by the lymphocyte count using preoperative hemograms. Receiver operating characteristic (ROC) analysis did not identify a significant PLR cut-off value for overall or disease-free survival. Therefore, patients were divided into two groups according to the median PLR value (<median vs. ≥median; patients with a PLR value equal to the median were assigned to the high-PLR group). Survival was analyzed using the Kaplan-Meier method and the log-rank test.Results: A total of 518 patients were included, and the median PLR was 124. PLR had no significant effect on disease-free survival or overall survival (p>0.05). Similarly, PLR had no significant effect on survival within any of the molecular subtypes (p>0.05).Conclusion: In this retrospective single-center study, PLR dichotomized at the median value of 124 was not associated with overall or disease-free survival in patients with breast cancer in univariable analyses. Prospective multicenter studies with multivariable analyses are needed to clarify the prognostic value of PLR.

DAHUDER Medical Journal(Advanced Online Publication)
Izmir Kâtip Çelebi University (TR)
Good health and well-being
Inflammatory Biomarkers in Disease Prognosis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon